Skip to main content
Fig. 3 | Hereditas

Fig. 3

From: Arecoline promotes proliferation and migration of human HepG2 cells through activation of the PI3K/AKT/mTOR pathway

Fig. 3

Effects of hub gene expression on prognosis of patients with hepatocellular cancer. Expression of the top 5 hub genes was assessed: CDK1, CCND1, RAF1, CDKN1B and BTRC. A Overall survival (OS) of patients showing high and low expression of CDK1. B Disease-free survival (DFS)of patients showing high and low expression of CDK1. C Expression of CDK1 in patients with hepatocellular cancer and healthy volunteers, *p < 0.001. D Expression of CDK1 in patients with hepatocellular cancer at different stages. E OS and DFS in patients showing high or low expression of CCND1. F OS and DFS in patients showing high or low expression of RAF1. G OS and DFS in patients showing high or low expression of CDKN1B. H OS and DFS in patients showing high or low expression of BTRC

Back to article page

Hereditas

ISSN: 1601-5223

Contact us